NCT04255563

Drug-coating Balloon Treatment in Coronary Artery Disease

Drug-coating Balloon Treatment in Coronary Artery Disease: a Prospective, Multicenter, Registry Study (ULTIMATE-DCB)

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 3,000 (estimated)
• Sponsor: Nanjing First Hospital, Nanjing Medical University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Drug-coated balloon (DCB) is an alternative choice for patients with coronary artery disease (CAD). This study is to investigate the efficacy and safety of DCB treatment in patients with CAD.

Detailed description

This is a prospective, multi-center, registry to enroll patients undergoing DCB treatment. All subjects undergoing DCB treatment will be enrolled in this study without strict inclusion and exclusion criteria. Data and images will be collected during the index procedure, and at the clinical and angiographic follow-up.

Conditions

• Coronary Artery Disease

Interventions

Type	Name	Description
DEVICE	DCB treatment	DCB (Sequent® Please) treatment for CAD patients will be enrolled. Intravascular ultrasound (Boston Scientific®) guidance is recommended.

Timeline

• Start date: 2020-02-25
• Primary completion: 2030-12-30
• Completion: 2030-12-30
• First posted: 2020-02-05
• Last updated: 2024-11-15

Locations

1 site across 1 country: China